# Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients

> **NCT06202027** · — · RECRUITING · sponsor: **Kyowa Kirin Korea Co., Ltd.** · enrollment: 100 (estimated)

## Conditions studied

- FGF23-related Hypophosphataemic Rickets and Osteomalacia

## Interventions

- **DRUG:** FGF23-related hypophosphataemic rickets and osteomalacia

## Key facts

- **NCT ID:** NCT06202027
- **Lead sponsor:** Kyowa Kirin Korea Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-11
- **Primary completion:** 2031-06-16
- **Final completion:** 2031-07-16
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-08-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06202027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06202027, "Post Marketing Surveillance Study to Observe Safety and Effectiveness of CRYSVITA® in S. Korean Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06202027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*